Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03996239 · ClinicalTrials.gov registry record · NA
Researching the Effect of Aerobic Exercise on Cancer
A NA study of Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 10
- Study locations
NCT03996239: Active NA study of Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03996239 is a NA study of Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 38 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 10 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03996239, a NA study of Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 10
- Study locations
Study Summary
This study is being done to answer the following question: Will aerobic exercise (exercise that stimulates and strengthens the heart and lungs, and improves the body's use of oxygen) change the biomarkers (signs of disease) found in the blood?
Primary Outcome
measured by targeted CH panel in peripheral blood
Conditions Studied
Interventions
- OTHER blood draw
- BEHAVIORAL exercise (walking)
- OTHER plasma samples
Study Locations (10)
New York
- Memorial Sloan Kettering Commack - Commack
- Memorial Sloan Kettering Westchester - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau - Uniondale
New Jersey
- Memorial Sloan Kettering Monmouth - Middletown
- Memorial Sloan Kettering Bergen - Montvale
North Carolina
- LABORATORY CORPORATION OF AMERICA HOLDINGS (Data or Specimen Analysis Only) - Burlington
- Duke University Medical Center (Data or Specimen Analysis Only) - Durham
California
- University of California, Los Angeles (Data or Specimen Analysis Only) - Los Angeles
Colorado
- SOMALOGIC (Data or Specimen Analysis Only) - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2019-06-20 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT03996239 still lists
NCT03996239 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which blood draw is the first listed.
NCT03996239 lists 10 locations in 5 states (New York, New Jersey, North Carolina).
Frequently Asked Questions
What is clinical trial NCT03996239 about?
NCT03996239 is a clinical study titled "Researching the Effect of Aerobic Exercise on Cancer". This study is being done to answer the following question: Will aerobic exercise (exercise that stimulates and strengthens the heart and lungs, and improves the body's use of oxygen) change the biomarkers (signs of disease) found in the blood?
What is the current status of trial NCT03996239?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2019-06-20. Estimated completion is 2026-06.
What conditions does trial NCT03996239 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT03996239?
The interventions under investigation include: blood draw (OTHER), exercise (walking) (BEHAVIORAL), plasma samples (OTHER).
Who is sponsoring clinical trial NCT03996239?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03996239 being conducted?
This trial has 10 study locations across California, Colorado, New Jersey, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03996239's enrollment target sits among peer trials
38 476th of 615 higher than 135 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
- NCT04237623 · 38 participants · Phase 2
GM-CSF With Post-Transplant Cyclophosphamide
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI